APO Research
Talk to an analyst

APO RESEARCH · REPORT

C1 Esterase Inhibitor Subcutaneous

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global C1 Esterase Inhibitor Subcutaneous Industry Growth and Trends Forecast to 2032

20 December 202575 pages

Choose your research edition.

Industry ResearchC1 Esterase Inhibitor Subcutaneous Industry Research Report 2026107 pages · $2,950 USDIndustry Growth & TrendsGlobal C1 Esterase Inhibitor Subcutaneous Industry Growth and Trends Forecast to 203275 pages · $3,450 USDMarket StructureGlobal C1 Esterase Inhibitor Subcutaneous Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal C1 Esterase Inhibitor Subcutaneous Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal C1 Esterase Inhibitor Subcutaneous Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global C1 Esterase Inhibitor Subcutaneous market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for C1 Esterase Inhibitor Subcutaneous is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for C1 Esterase Inhibitor Subcutaneous is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for C1 Esterase Inhibitor Subcutaneous is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of C1 Esterase Inhibitor Subcutaneous include Takeda and CSL Behring among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global C1 Esterase Inhibitor Subcutaneous market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The C1 Esterase Inhibitor Subcutaneous market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global C1 Esterase Inhibitor Subcutaneous market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to C1 Esterase Inhibitor Subcutaneous.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global C1 Esterase Inhibitor Subcutaneous market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

C1 Esterase Inhibitor Subcutaneous Market by Company

Takeda

CSL Behring

C1 Esterase Inhibitor Subcutaneous Segment by Type

500U

1000U

C1 Esterase Inhibitor Subcutaneous Segment by Application

Children

Adult

C1 Esterase Inhibitor Subcutaneous Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global C1 Esterase Inhibitor Subcutaneous market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of C1 Esterase Inhibitor Subcutaneous and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of C1 Esterase Inhibitor Subcutaneous.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of C1 Esterase Inhibitor Subcutaneous manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of C1 Esterase Inhibitor Subcutaneous in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 500U Table 2. Major Company of 1000U Table 3. Global C1 Esterase Inhibitor Subcutaneous Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global C1 Esterase Inhibitor Subcutaneous Sales by Type (2021-2026) & (k units) Table 5. Global C1 Esterase Inhibitor Subcutaneous Sales Market Share in Volume by Type (2021-2026) Table 6. Global C1 Esterase Inhibitor Subcutaneous Sales by Type (2021-2026) & (US$ Million) Table 7. Global C1 Esterase Inhibitor Subcutaneous Sales Market Share in Value by Type (2021-2026) Table 8. Global C1 Esterase Inhibitor Subcutaneous Price by Type (2021-2026) & (US$/unit) Table 9. Global C1 Esterase Inhibitor Subcutaneous Sales by Type (2027-2032) & (k units) Table 10. Global C1 Esterase Inhibitor Subcutaneous Sales Market Share in Volume by Type (2027-2032) Table 11. Global C1 Esterase Inhibitor Subcutaneous Sales by Type (2027-2032) & (US$ Million) Table 12. Global C1 Esterase Inhibitor Subcutaneous Sales Market Share in Value by Type (2027-2032) Table 13. Global C1 Esterase Inhibitor Subcutaneous Price by Type (2027-2032) & (US$/unit) Table 14. North America C1 Esterase Inhibitor Subcutaneous Sales by Type (2021-2026) & (k units) Table 15. North America C1 Esterase Inhibitor Subcutaneous Sales by Type (2021-2026) & (US$ Million) Table 16. Europe C1 Esterase Inhibitor Subcutaneous Sales by Type (2021-2026) & (k units) Table 17. Europe C1 Esterase Inhibitor Subcutaneous Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific C1 Esterase Inhibitor Subcutaneous Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific C1 Esterase Inhibitor Subcutaneous Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America C1 Esterase Inhibitor Subcutaneous Sales by Type (2021-2026) & (k units) Table 21. Latin America C1 Esterase Inhibitor Subcutaneous Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa C1 Esterase Inhibitor Subcutaneous Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa C1 Esterase Inhibitor Subcutaneous Sales by Type (2021-2026) & (US$ Million) Table 24. C1 Esterase Inhibitor Subcutaneous Industry Trends Table 25. C1 Esterase Inhibitor Subcutaneous Industry Drivers Table 26. C1 Esterase Inhibitor Subcutaneous Industry Opportunities and Challenges Table 27. C1 Esterase Inhibitor Subcutaneous Industry Restraints Table 28. Global C1 Esterase Inhibitor Subcutaneous Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global C1 Esterase Inhibitor Subcutaneous Revenue Market Share by Company (2021-2026) Table 30. Global C1 Esterase Inhibitor Subcutaneous Sales by Company (2021-2026) & (k units) Table 31. Global C1 Esterase Inhibitor Subcutaneous Sales Share by Company (2021-2026) Table 32. Global C1 Esterase Inhibitor Subcutaneous Market Price by Company (2021-2026) & (US$/unit) Table 33. Global C1 Esterase Inhibitor Subcutaneous Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global C1 Esterase Inhibitor Subcutaneous Major Company Production Sites and Headquarters Table 35. Global C1 Esterase Inhibitor Subcutaneous Company, Product Type & Application Table 36. Global C1 Esterase Inhibitor Subcutaneous Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global C1 Esterase Inhibitor Subcutaneous by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global C1 Esterase Inhibitor Subcutaneous Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global C1 Esterase Inhibitor Subcutaneous Sales by Region (2021-2026) & (k units) Table 41. Global C1 Esterase Inhibitor Subcutaneous Sales Market Share in Volume by Region (2021-2026) Table 42. Global C1 Esterase Inhibitor Subcutaneous Sales by Region (2021-2026) & (US$ Million) Table 43. Global C1 Esterase Inhibitor Subcutaneous Sales Market Share in Value by Region (2021-2026) Table 44. Global C1 Esterase Inhibitor Subcutaneous Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global C1 Esterase Inhibitor Subcutaneous Sales by Region (2027-2032) & (k units) Table 46. Global C1 Esterase Inhibitor Subcutaneous Sales Market Share in Volume by Region (2027-2032) Table 47. Global C1 Esterase Inhibitor Subcutaneous Sales by Region (2027-2032) & (US$ Million) Table 48. Global C1 Esterase Inhibitor Subcutaneous Sales Market Share in Value by Region (2027-2032) Table 49. Global C1 Esterase Inhibitor Subcutaneous Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global C1 Esterase Inhibitor Subcutaneous Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global C1 Esterase Inhibitor Subcutaneous Sales by Application (2021-2026) & (k units) Table 52. Global C1 Esterase Inhibitor Subcutaneous Sales Market Share in Volume by Application (2021-2026) Table 53. Global C1 Esterase Inhibitor Subcutaneous Sales by Application (2021-2026) & (US$ Million) Table 54. Global C1 Esterase Inhibitor Subcutaneous Sales Market Share in Value by Application (2021-2026) Table 55. Global C1 Esterase Inhibitor Subcutaneous Price by Application (2021-2026) & (US$/unit) Table 56. Global C1 Esterase Inhibitor Subcutaneous Sales by Application (2027-2032) & (k units) Table 57. Global C1 Esterase Inhibitor Subcutaneous Sales Market Share in Volume by Application (2027-2032) Table 58. Global C1 Esterase Inhibitor Subcutaneous Sales by Application (2027-2032) & (US$ Million) Table 59. Global C1 Esterase Inhibitor Subcutaneous Sales Market Share in Value by Application (2027-2032) Table 60. Global C1 Esterase Inhibitor Subcutaneous Price by Application (2027-2032) & (US$/unit) Table 61. North America C1 Esterase Inhibitor Subcutaneous Sales by Application (2021-2026) & (k units) Table 62. North America C1 Esterase Inhibitor Subcutaneous Sales by Application (2021-2026) & (US$ Million) Table 63. Europe C1 Esterase Inhibitor Subcutaneous Sales by Application (2021-2026) & (k units) Table 64. Europe C1 Esterase Inhibitor Subcutaneous Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific C1 Esterase Inhibitor Subcutaneous Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific C1 Esterase Inhibitor Subcutaneous Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America C1 Esterase Inhibitor Subcutaneous Sales by Application (2021-2026) & (k units) Table 68. Latin America C1 Esterase Inhibitor Subcutaneous Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa C1 Esterase Inhibitor Subcutaneous Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa C1 Esterase Inhibitor Subcutaneous Sales by Application (2021-2026) & (US$ Million) Table 71. Takeda Company Information Table 72. Takeda Business Overview Table 73. Takeda C1 Esterase Inhibitor Subcutaneous Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Takeda C1 Esterase Inhibitor Subcutaneous Product Portfolio Table 75. Takeda Recent Development Table 76. CSL Behring Company Information Table 77. CSL Behring Business Overview Table 78. CSL Behring C1 Esterase Inhibitor Subcutaneous Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. CSL Behring C1 Esterase Inhibitor Subcutaneous Product Portfolio Table 80. CSL Behring Recent Development Table 81. North America C1 Esterase Inhibitor Subcutaneous Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 82. North America C1 Esterase Inhibitor Subcutaneous Sales by Country (2021-2026) & (k units) Table 83. North America C1 Esterase Inhibitor Subcutaneous Sales Market Share by Country (2021-2026) Table 84. North America C1 Esterase Inhibitor Subcutaneous Sales Forecast by Country (2027-2032) & (k units) Table 85. North America C1 Esterase Inhibitor Subcutaneous Sales Market Share Forecast by Country (2027-2032) Table 86. North America C1 Esterase Inhibitor Subcutaneous Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 87. North America C1 Esterase Inhibitor Subcutaneous Market Size by Country (2021-2026) & (US$ Million) Table 88. North America C1 Esterase Inhibitor Subcutaneous Market Share by Country (2021-2026) Table 89. North America C1 Esterase Inhibitor Subcutaneous Market Size Forecast by Country (2027-2032) & (US$ Million) Table 90. North America C1 Esterase Inhibitor Subcutaneous Market Share Forecast by Country (2027-2032) Table 91. Europe C1 Esterase Inhibitor Subcutaneous Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 92. Europe C1 Esterase Inhibitor Subcutaneous Sales by Country (2021-2026) & (k units) Table 93. Europe C1 Esterase Inhibitor Subcutaneous Sales Market Share by Country (2021-2026) Table 94. Europe C1 Esterase Inhibitor Subcutaneous Sales Forecast by Country (2027-2032) & (k units) Table 95. Europe C1 Esterase Inhibitor Subcutaneous Sales Market Share Forecast by Country (2027-2032) Table 96. Europe C1 Esterase Inhibitor Subcutaneous Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 97. Europe C1 Esterase Inhibitor Subcutaneous Market Size by Country (2021-2026) & (US$ Million) Table 98. Europe C1 Esterase Inhibitor Subcutaneous Market Share by Country (2021-2026) Table 99. Europe C1 Esterase Inhibitor Subcutaneous Market Size Forecast by Country (2027-2032) & (US$ Million) Table 100. Europe C1 Esterase Inhibitor Subcutaneous Market Share Forecast by Country (2027-2032) Table 101. Asia-Pacific C1 Esterase Inhibitor Subcutaneous Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 102. Asia-Pacific C1 Esterase Inhibitor Subcutaneous Sales by Country (2021-2026) & (k units) Table 103. Asia-Pacific C1 Esterase Inhibitor Subcutaneous Sales Market Share by Country (2021-2026) Table 104. Asia-Pacific C1 Esterase Inhibitor Subcutaneous Sales Forecast by Country (2027-2032) & (k units) Table 105. Asia-Pacific C1 Esterase Inhibitor Subcutaneous Sales Market Share Forecast by Country (2027-2032) Table 106. Asia-Pacific C1 Esterase Inhibitor Subcutaneous Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. Asia-Pacific C1 Esterase Inhibitor Subcutaneous Market Size by Country (2021-2026) & (US$ Million) Table 108. Asia-Pacific C1 Esterase Inhibitor Subcutaneous Market Share by Country (2021-2026) Table 109. Asia-Pacific C1 Esterase Inhibitor Subcutaneous Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. Asia-Pacific C1 Esterase Inhibitor Subcutaneous Market Share Forecast by Country (2027-2032) Table 111. Latin America C1 Esterase Inhibitor Subcutaneous Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 112. Latin America C1 Esterase Inhibitor Subcutaneous Sales by Country (2021-2026) & (k units) Table 113. Latin America C1 Esterase Inhibitor Subcutaneous Sales Market Share by Country (2021-2026) Table 114. Latin America C1 Esterase Inhibitor Subcutaneous Sales Forecast by Country (2027-2032) & (k units) Table 115. Latin America C1 Esterase Inhibitor Subcutaneous Sales Market Share Forecast by Country (2027-2032) Table 116. Latin America C1 Esterase Inhibitor Subcutaneous Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Latin America C1 Esterase Inhibitor Subcutaneous Market Size by Country (2021-2026) & (US$ Million) Table 118. Latin America C1 Esterase Inhibitor Subcutaneous Market Share by Country (2021-2026) Table 119. Latin America C1 Esterase Inhibitor Subcutaneous Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Latin America C1 Esterase Inhibitor Subcutaneous Market Share Forecast by Country (2027-2032) Table 121. Middle East and Africa C1 Esterase Inhibitor Subcutaneous Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 122. Middle East and Africa C1 Esterase Inhibitor Subcutaneous Sales by Country (2021-2026) & (k units) Table 123. Middle East and Africa C1 Esterase Inhibitor Subcutaneous Sales Market Share by Country (2021-2026) Table 124. Middle East and Africa C1 Esterase Inhibitor Subcutaneous Sales Forecast by Country (2027-2032) & (k units) Table 125. Middle East and Africa C1 Esterase Inhibitor Subcutaneous Sales Market Share Forecast by Country (2027-2032) Table 126. Middle East and Africa C1 Esterase Inhibitor Subcutaneous Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Middle East and Africa C1 Esterase Inhibitor Subcutaneous Market Size by Country (2021-2026) & (US$ Million) Table 128. Middle East and Africa C1 Esterase Inhibitor Subcutaneous Market Share by Country (2021-2026) Table 129. Middle East and Africa C1 Esterase Inhibitor Subcutaneous Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Middle East and Africa C1 Esterase Inhibitor Subcutaneous Market Share Forecast by Country (2027-2032) Table 131. Key Raw Materials Table 132. Raw Materials Key Suppliers Table 133. C1 Esterase Inhibitor Subcutaneous Distributors List Table 134. C1 Esterase Inhibitor Subcutaneous Customers List Table 135. Research Programs/Design for This Report Table 136. Authors List of This Report Table 137. Secondary Sources Table 138. Primary Sources List of Figures Figure 1. C1 Esterase Inhibitor Subcutaneous Image Figure 2. Global C1 Esterase Inhibitor Subcutaneous Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global C1 Esterase Inhibitor Subcutaneous Market Size (2021-2032) & (US$ Million) Figure 4. Global C1 Esterase Inhibitor Subcutaneous Sales (2021-2032) & (k units) Figure 5. 500U Image Figure 6. Global 500U Sales YoY Growth (2021-2032) & (k units) Figure 7. 1000U Image Figure 8. Global 1000U Sales YoY Growth (2021-2032) & (k units) Figure 9. Global C1 Esterase Inhibitor Subcutaneous Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global C1 Esterase Inhibitor Subcutaneous Market Share by Type 2025 VS 2032 Figure 11. North America C1 Esterase Inhibitor Subcutaneous Sales Market Share in Volume by Type in 2025 Figure 12. North America C1 Esterase Inhibitor Subcutaneous Sales Market Share in Value by Type in 2025 Figure 13. Europe C1 Esterase Inhibitor Subcutaneous Sales Market Share in Volume by Type in 2025 Figure 14. Europe C1 Esterase Inhibitor Subcutaneous Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific C1 Esterase Inhibitor Subcutaneous Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific C1 Esterase Inhibitor Subcutaneous Sales Market Share in Value by Type in 2025 Figure 17. Latin America C1 Esterase Inhibitor Subcutaneous Sales Market Share in Volume by Type in 2025 Figure 18. Latin America C1 Esterase Inhibitor Subcutaneous Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa C1 Esterase Inhibitor Subcutaneous Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa C1 Esterase Inhibitor Subcutaneous Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 C1 Esterase Inhibitor Subcutaneous Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Children Image Figure 24. Global Children Sales YoY Growth (2021-2032) & (k units) Figure 25. Adult Image Figure 26. Global Adult Sales YoY Growth (2021-2032) & (k units) Figure 27. Global C1 Esterase Inhibitor Subcutaneous Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global C1 Esterase Inhibitor Subcutaneous Market Share by Application 2025 VS 2032 Figure 29. North America C1 Esterase Inhibitor Subcutaneous Sales Market Share in Volume by Application in 2025 Figure 30. North America C1 Esterase Inhibitor Subcutaneous Sales Market Share in Value by Application in 2025 Figure 31. Europe C1 Esterase Inhibitor Subcutaneous Sales Market Share in Volume by Application in 2025 Figure 32. Europe C1 Esterase Inhibitor Subcutaneous Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific C1 Esterase Inhibitor Subcutaneous Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific C1 Esterase Inhibitor Subcutaneous Sales Market Share in Value by Application in 2025 Figure 35. Latin America C1 Esterase Inhibitor Subcutaneous Sales Market Share in Volume by Application in 2025 Figure 36. Latin America C1 Esterase Inhibitor Subcutaneous Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa C1 Esterase Inhibitor Subcutaneous Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa C1 Esterase Inhibitor Subcutaneous Sales Market Share in Value by Application in 2025 Figure 39. North America C1 Esterase Inhibitor Subcutaneous Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America C1 Esterase Inhibitor Subcutaneous Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America C1 Esterase Inhibitor Subcutaneous Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America C1 Esterase Inhibitor Subcutaneous Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe C1 Esterase Inhibitor Subcutaneous Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe C1 Esterase Inhibitor Subcutaneous Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe C1 Esterase Inhibitor Subcutaneous Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe C1 Esterase Inhibitor Subcutaneous Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific C1 Esterase Inhibitor Subcutaneous Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific C1 Esterase Inhibitor Subcutaneous Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific C1 Esterase Inhibitor Subcutaneous Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific C1 Esterase Inhibitor Subcutaneous Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America C1 Esterase Inhibitor Subcutaneous Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America C1 Esterase Inhibitor Subcutaneous Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America C1 Esterase Inhibitor Subcutaneous Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America C1 Esterase Inhibitor Subcutaneous Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa C1 Esterase Inhibitor Subcutaneous Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa C1 Esterase Inhibitor Subcutaneous Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa C1 Esterase Inhibitor Subcutaneous Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa C1 Esterase Inhibitor Subcutaneous Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. C1 Esterase Inhibitor Subcutaneous Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. C1 Esterase Inhibitor Subcutaneous Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • 500U
  • 1000U
Applications
  • Children
  • Adult
Companies covered
  • Takeda
  • CSL Behring

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global C1 Esterase Inhibitor Subcutaneous Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global C1 Esterase Inhibitor Subcutaneous Sales Estimates and Forecasts (2021-2032)
  5. 1.3 C1 Esterase Inhibitor Subcutaneous Market by Type
  6. 1.3.1 500U
  7. 1.3.2 1000U
  8. 1.4 Global C1 Esterase Inhibitor Subcutaneous Market Size by Type
  9. 1.4.1 Global C1 Esterase Inhibitor Subcutaneous Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global C1 Esterase Inhibitor Subcutaneous Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global C1 Esterase Inhibitor Subcutaneous Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America C1 Esterase Inhibitor Subcutaneous Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe C1 Esterase Inhibitor Subcutaneous Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific C1 Esterase Inhibitor Subcutaneous Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America C1 Esterase Inhibitor Subcutaneous Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa C1 Esterase Inhibitor Subcutaneous Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 C1 Esterase Inhibitor Subcutaneous Industry Trends
  2. 2.2 C1 Esterase Inhibitor Subcutaneous Industry Drivers
  3. 2.3 C1 Esterase Inhibitor Subcutaneous Industry Opportunities and Challenges
  4. 2.4 C1 Esterase Inhibitor Subcutaneous Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by C1 Esterase Inhibitor Subcutaneous Revenue (2021-2026)
  2. 3.2 Global Top Players by C1 Esterase Inhibitor Subcutaneous Sales (2021-2026)
  3. 3.3 Global Top Players by C1 Esterase Inhibitor Subcutaneous Price (2021-2026)
  4. 3.4 Global C1 Esterase Inhibitor Subcutaneous Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global C1 Esterase Inhibitor Subcutaneous Major Company Production Sites & Headquarters
  6. 3.6 Global C1 Esterase Inhibitor Subcutaneous Company, Product Type & Application
  7. 3.7 Global C1 Esterase Inhibitor Subcutaneous Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global C1 Esterase Inhibitor Subcutaneous Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 C1 Esterase Inhibitor Subcutaneous Players Market Share by Revenue in 2025
  11. 3.8.3 2025 C1 Esterase Inhibitor Subcutaneous Tier 1, Tier 2, and Tier 3
4 C1 Esterase Inhibitor Subcutaneous Regional Status and Outlook
  1. 4.1 Global C1 Esterase Inhibitor Subcutaneous Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global C1 Esterase Inhibitor Subcutaneous Historic Market Size by Region
  3. 4.2.1 Global C1 Esterase Inhibitor Subcutaneous Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global C1 Esterase Inhibitor Subcutaneous Sales in Value by Region (2021-2026)
  5. 4.2.3 Global C1 Esterase Inhibitor Subcutaneous Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global C1 Esterase Inhibitor Subcutaneous Forecasted Market Size by Region
  7. 4.3.1 Global C1 Esterase Inhibitor Subcutaneous Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global C1 Esterase Inhibitor Subcutaneous Sales in Value by Region (2027-2032)
  9. 4.3.3 Global C1 Esterase Inhibitor Subcutaneous Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 C1 Esterase Inhibitor Subcutaneous by Application
  1. 5.1 C1 Esterase Inhibitor Subcutaneous Market by Application
  2. 5.1.1 Children
  3. 5.1.2 Adult
  4. 5.2 Global C1 Esterase Inhibitor Subcutaneous Market Size by Application
  5. 5.2.1 Global C1 Esterase Inhibitor Subcutaneous Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global C1 Esterase Inhibitor Subcutaneous Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global C1 Esterase Inhibitor Subcutaneous Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America C1 Esterase Inhibitor Subcutaneous Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe C1 Esterase Inhibitor Subcutaneous Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific C1 Esterase Inhibitor Subcutaneous Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America C1 Esterase Inhibitor Subcutaneous Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa C1 Esterase Inhibitor Subcutaneous Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda C1 Esterase Inhibitor Subcutaneous Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda C1 Esterase Inhibitor Subcutaneous Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 CSL Behring
  8. 6.2.1 CSL Behring Company Information
  9. 6.2.2 CSL Behring Business Overview
  10. 6.2.3 CSL Behring C1 Esterase Inhibitor Subcutaneous Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 CSL Behring C1 Esterase Inhibitor Subcutaneous Product Portfolio
  12. 6.2.5 CSL Behring Recent Developments
7 North America by Country
  1. 7.1 North America C1 Esterase Inhibitor Subcutaneous Sales by Country
  2. 7.1.1 North America C1 Esterase Inhibitor Subcutaneous Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America C1 Esterase Inhibitor Subcutaneous Sales by Country (2021-2026)
  4. 7.1.3 North America C1 Esterase Inhibitor Subcutaneous Sales Forecast by Country (2027-2032)
  5. 7.2 North America C1 Esterase Inhibitor Subcutaneous Market Size by Country
  6. 7.2.1 North America C1 Esterase Inhibitor Subcutaneous Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America C1 Esterase Inhibitor Subcutaneous Market Size by Country (2021-2026)
  8. 7.2.3 North America C1 Esterase Inhibitor Subcutaneous Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe C1 Esterase Inhibitor Subcutaneous Sales by Country
  2. 8.1.1 Europe C1 Esterase Inhibitor Subcutaneous Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe C1 Esterase Inhibitor Subcutaneous Sales by Country (2021-2026)
  4. 8.1.3 Europe C1 Esterase Inhibitor Subcutaneous Sales Forecast by Country (2027-2032)
  5. 8.2 Europe C1 Esterase Inhibitor Subcutaneous Market Size by Country
  6. 8.2.1 Europe C1 Esterase Inhibitor Subcutaneous Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe C1 Esterase Inhibitor Subcutaneous Market Size by Country (2021-2026)
  8. 8.2.3 Europe C1 Esterase Inhibitor Subcutaneous Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific C1 Esterase Inhibitor Subcutaneous Sales by Country
  2. 9.1.1 Asia-Pacific C1 Esterase Inhibitor Subcutaneous Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific C1 Esterase Inhibitor Subcutaneous Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific C1 Esterase Inhibitor Subcutaneous Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific C1 Esterase Inhibitor Subcutaneous Market Size by Country
  6. 9.2.1 Asia-Pacific C1 Esterase Inhibitor Subcutaneous Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific C1 Esterase Inhibitor Subcutaneous Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific C1 Esterase Inhibitor Subcutaneous Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America C1 Esterase Inhibitor Subcutaneous Sales by Country
  2. 10.1.1 South America C1 Esterase Inhibitor Subcutaneous Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America C1 Esterase Inhibitor Subcutaneous Sales by Country (2021-2026)
  4. 10.1.3 South America C1 Esterase Inhibitor Subcutaneous Sales Forecast by Country (2027-2032)
  5. 10.2 South America C1 Esterase Inhibitor Subcutaneous Market Size by Country
  6. 10.2.1 South America C1 Esterase Inhibitor Subcutaneous Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America C1 Esterase Inhibitor Subcutaneous Market Size by Country (2021-2026)
  8. 10.2.3 South America C1 Esterase Inhibitor Subcutaneous Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa C1 Esterase Inhibitor Subcutaneous Sales by Country
  2. 11.1.1 Middle East and Africa C1 Esterase Inhibitor Subcutaneous Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa C1 Esterase Inhibitor Subcutaneous Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa C1 Esterase Inhibitor Subcutaneous Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa C1 Esterase Inhibitor Subcutaneous Market Size by Country
  6. 11.2.1 Middle East and Africa C1 Esterase Inhibitor Subcutaneous Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa C1 Esterase Inhibitor Subcutaneous Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa C1 Esterase Inhibitor Subcutaneous Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 C1 Esterase Inhibitor Subcutaneous Value Chain Analysis
  2. 12.1.1 C1 Esterase Inhibitor Subcutaneous Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 C1 Esterase Inhibitor Subcutaneous Production Mode & Process
  7. 12.2 C1 Esterase Inhibitor Subcutaneous Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 C1 Esterase Inhibitor Subcutaneous Distributors
  10. 12.2.3 C1 Esterase Inhibitor Subcutaneous Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst